US equities |
MU $1,029.00 ▼-0.66% NVDA $229.28 ▼-0.52% SPCX $162.57 ▲+1.25% TSLA $382.70 ▲+2.05% AAPL $336.64 ▼-1.11% MSFT $535.07 ▲+2.38% AMZN $262.43 ▲+3.29% META $718.67 ▼-0.31%
FinancialContent

Fortrea Holdings Inc. - Common Stock (NQ:FTRE)

20.84 +0.47 (+2.31%)
Delayed Quote Updated: 4:00 PM EDT, Oct 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Fortrea Holdings Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
News headline image
3 Overrated Stocks We Think Twice About
Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a ne... 
Via StockStory
News headline image
Fortrea (FTRE) Stock Trades Up, Here Is Why
What Happened? Shares of clinical research company Fortrea Holdings (NASDAQ:FTRE) jumped 3.3% in the pre-market session after Barclays upgraded the company t... 
Via StockStory
Topics Artificial Intelligence Earnings Initial Public Offering
News headline image
Fortrea Announces Date for Third Quarter 2026 Financial Results and Conference Call
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
2 Volatile Stocks to Consider Right Now and 1 We Find Risky
Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains. This unpredictability ... 
Via StockStory
Fortrea Holdings (NASDAQ:FTRE) Jumps After Q2 Earnings Beat and Raised Full-Year Outlook ↗
Via Chartmill
Topics Earnings
News headline image
1 Momentum Stock to Research Further and 2 We Turn Down
The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorab... 
Via StockStory
News headline image
3 Healthcare Stocks That Concern Us
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from eleva... 
Via StockStory
News headline image
3 Cash-Producing Stocks That Concern Us
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Not... 
Via StockStory
News headline image
2 Small-Cap Stocks to Research Further and 1 Facing Challenges
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in th... 
Via StockStory
Topics Energy
News headline image
2 of Wall Street’s Favorite Stocks to Target This Week and 1 Facing Challenges
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptic... 
Via StockStory
News headline image
Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
Fortrea to Participate in September Investor Conferences
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
Stocks making big moves this week: SAIC, Reddit, Fortrea, GitLab, and G-III
Check out the companies making headlines this week: SAIC (NASDAQ:SAIC): Government IT services provider Science Applications International Corporation (NASDA... 
Via StockStory
News headline image
Stocks making big moves yesterday: Limbach, FuelCell Energy, Ollie's, Fortrea, and G-III
Check out the companies making headlines yesterday: Limbach (NASDAQ:LMB): Building systems company Limbach (NASDAQ:LMB) rose by 8.1% on Wednesday after the s... 
Via StockStory
News headline image
Fortrea (FTRE) Stock Is Up, What You Need To Know
What Happened? Shares of clinical research company Fortrea Holdings (NASDAQ:FTRE) jumped 3% in the afternoon session after the company agreed to acquire the ... 
Via StockStory
Topics Earnings Initial Public Offering
News headline image
Fortrea to Acquire Clinical Pharmacology Unit and Bioanalytical Laboratory Operations from Worldwide Clinical Trials
Adds dedicated bioanalytical capabilities and expanded capacity to Fortrea’s early clinical development network as Worldwide advances its strategy to scale clinical development, therapeutic leadership... 
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
Fortrea (FTRE): Buy, Sell, or Hold Post Q2 Earnings?
Fortrea has been on fire lately. In the past six months alone, the company’s stock price has rocketed 77%, reaching $18.31 per share. This was partly due to ... 
Via StockStory
News headline image
Drug Development Inputs & Services Stocks Q2 In Review: Fortrea (NASDAQ:FTRE) Vs Peers
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at ... 
Via StockStory
News headline image
Fortrea (FTRE) Q2 2026 Earnings Call Transcript ↗
Biotech demand strengthens as backlog hits $7.8 billion and guidance rises. 
Via The Motley Fool
Topics Earnings
News headline image
Fortrea Q2 Earnings Call Highlights ↗
Fortrea (NASDAQ:FTRE) reported second-quarter 2026 revenue of $678.2 million and adjusted EBITDA of $58.7 million, while raising its full-year revenue and adjusted EBITDA outlook. Management said... 
Via MarketBeat
Topics Earnings
News headline image
Fortrea (NASDAQ:FTRE) Reports Strong Q2 CY2026, Full-Year Sales Guidance is Optimistic
Clinical research company Fortrea Holdings (NASDAQ:FTRE) reported Q2 CY2026 results exceeding the market’s revenue expectations, but sales fell by 4.5% year ... 
Via StockStory
News headline image
Fortrea Reports Second Quarter 2026 Results
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
Fortrea Earnings: What To Look For From FTRE
Clinical research company Fortrea Holdings (NASDAQ:FTRE) will be announcing earnings results this Wednesday morning. Here’s what to look for. Fortrea beat an... 
Via StockStory
Topics Artificial Intelligence
News headline image
Kaskela Law Firm Announces Investigation of Fortrea Holdings Inc. (FTRE) and Encourages Long-Term FTRE Shareholders with Investment Losses to Contact the Firm
From Kaskela Law LLC
Via Business Wire
News headline image
3 Reasons to Sell FTRE and 1 Stock to Buy Instead
Fortrea trades at $17.93 and has moved in lockstep with the market. Its shares have returned 13.3% over the last six months while the S&P 500 has gained 11.4... 
Via StockStory
Topics Artificial Intelligence Stocks
News headline image
Fortrea Announces Date for Second Quarter 2026 Financial Results and Conference Call
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
3 Overrated Stocks Walking a Fine Line
The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorab... 
Via StockStory
News headline image
1 Russell 2000 Stock Worth Your Attention and 2 That Underwhelm
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size ... 
Via StockStory
News headline image
Fortrea Names Jason Knoblauch as Chief Financial Officer
Jason Knoblauch will succeed Jill McConnell as chief financial officer of Fortrea 
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
Stocks making big moves yesterday: Fortrea, Kura Sushi, Energizer, Bath and Body Works, and Robinhood
Check out the companies making headlines yesterday: Fortrea (NASDAQ:FTRE): Clinical research company Fortrea Holdings (NASDAQ:FTRE) rose by 4.6% on Wednesday... 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >